Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

SLNO – Soleno Therapeutics Inc

Soleno Therapeutics, Inc.
SLNO
$86.00
Name : Soleno Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $4,536,233,472.00
EPSttm : -4.74
finviz dynamic chart for SLNO
Soleno Therapeutics, Inc.
$86.00
0.54%
$0.47

Float Short %

13.27

Margin Of Safety %

Put/Call OI Ratio

1.1

EPS Next Q Diff

0.95

EPS Last/This Y

4.38

EPS This/Next Y

Price

86

Target Price

114.56

Analyst Recom

1.11

Performance Q

14.64

Relative Volume

0.97

Beta

-2.56

Ticker: SLNO




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04SLNO86.651.020.1345409
2025-07-07SLNO85.191.010.3245647
2025-07-08SLNO85.261.010.8245855
2025-07-09SLNO88.051.010.4845943
2025-07-10SLNO80.760.990.5447582
2025-07-11SLNO81.431.010.1150171
2025-07-14SLNO82.760.990.2651488
2025-07-15SLNO83.150.942.0954010
2025-07-16SLNO85.520.941.0154038
2025-07-17SLNO87.710.940.7054101
2025-07-18SLNO87.190.945.1254200
2025-07-21SLNO87.011.078.6137229
2025-07-22SLNO86.051.090.5337705
2025-07-23SLNO87.51.090.3837729
2025-07-24SLNO88.031.090.1537732
2025-07-25SLNO86.481.085.3237619
2025-07-28SLNO85.31.101.5437956
2025-07-29SLNO83.971.101.1837982
2025-07-30SLNO84.861.100.2637972
2025-07-31SLNO86.461.100.0037994
2025-08-01SLNO86.041.102.6037972
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04SLNO86.65- - 0.00
2025-07-07SLNO85.25- - 0.00
2025-07-08SLNO85.26- - 0.00
2025-07-09SLNO88.49- - 0.00
2025-07-10SLNO80.32- - 0.00
2025-07-11SLNO81.57- - 0.00
2025-07-14SLNO82.76- - 0.00
2025-07-15SLNO83.59- - 0.00
2025-07-16SLNO85.57- - 0.00
2025-07-17SLNO87.64- - 0.00
2025-07-18SLNO87.19- - 0.00
2025-07-21SLNO87.00- - 0.00
2025-07-22SLNO86.05- - 0.00
2025-07-23SLNO87.45- - 0.00
2025-07-24SLNO88.03- - 0.00
2025-07-25SLNO86.47- - 0.00
2025-07-28SLNO85.62- - 0.00
2025-07-29SLNO83.97- - 0.00
2025-07-30SLNO84.86- - 0.00
2025-07-31SLNO86.47- - 0.00
2025-08-01SLNO86.00- - 0.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04SLNO-25.709.509.73
2025-07-07SLNO-25.469.569.73
2025-07-08SLNO-25.469.569.73
2025-07-09SLNO-25.469.569.73
2025-07-10SLNO-25.469.569.73
2025-07-11SLNO-25.469.5612.82
2025-07-14SLNO-25.469.4112.82
2025-07-15SLNO-25.469.4112.82
2025-07-16SLNO-24.619.4112.25
2025-07-17SLNO-24.619.4112.25
2025-07-18SLNO-24.619.4112.25
2025-07-21SLNO-24.616.8812.25
2025-07-22SLNO-24.616.8812.25
2025-07-23SLNO-24.616.8812.25
2025-07-24SLNO-24.616.8812.25
2025-07-25SLNO-24.616.8813.42
2025-07-28SLNO-24.619.3913.27
2025-07-29SLNO-25.699.3913.27
2025-07-30SLNO-25.699.3913.27
2025-07-31SLNO-25.699.3913.27
2025-08-01SLNO-25.699.3913.27
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.95

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

-25.69

Institutional Transactions

9.39

Beta

-2.56

Average Sales Estimate Current Quarter

3

Average Sales Estimate Next Quarter

35

Fair Value

Quality Score

9

Growth Score

22

Sentiment Score

31

Actual DrawDown %

4.8

Max Drawdown 5-Year %

-98.2

Target Price

114.56

P/E

Forward P/E

52.76

PEG

P/S

P/B

17.97

P/Free Cash Flow

EPS

-4.62

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.97

Return on Equity vs Sector %

-109.1

Return on Equity vs Industry %

-90.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Soleno Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 115
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today
news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance
stock history SLNO – Soleno Therapeutics Inc invest stock market
stock prices SLNO premarket after hours
ticker SLNO fair value insiders trading